Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy ( BRIT )
Clinical & Experimental Allergy · 2025-06 · 55 (6) · 458-468
DOI: 10.1111/cea.70034 ↗At a glance
Journal article in Clinical & Experimental Allergy, published online on 2025-04-01. Written by Mich Erlewyn-Lajeunesse and 15 co-authors. Institution: University of Southampton and Southampton Children's Hospital, Southampton, UK. Major MEDLINE topics: Health Services Accessibility, Desensitization, Immunologic, Healthcare Disparities, Hypersensitivity. Cited 9 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
There is an unmet need for specialist allergy treatment in the United Kingdom. Allergen immunotherapy and treatment with omalizumab for chronic spontaneous urticaria (CSU) are key markers for these services. The British Society for Allergy and Clinical Immunology (BSACI) Registry for Immunotherapy (BRIT) is a national project to record the real‐world effectiveness, safety and access to treatment for aero‐allergen, venom and peanut immunotherapy as well as omalizumab for CSU.
Methods
We described participant demographics, the index of multiple deprivation (IMD) and access to treatment from the registry launch. Data for 1835 participants were available for analysis from 63 centres enrolled between 1st October 2018 and 24th August 2023.
Results
96.5% (1771/1835) were living in England, with only 3.5% (64) being from the devolved nations. 14.4% (251/1748) were in the most affluent IMD decile compared to 4.5% (78/1748) in the most deprived IMD decile. White participants were 1.74 times more likely to be referred directly from primary care compared to people of Asian, black, mixed or other minority ethnic groups. Instead, these groups were referred more frequently from secondary or tertiary hospital services. The median distance travelled from home to the treatment centre was 15.2 miles, with evidence of clustering around specialist centres.
Conclusions
We have described disparities and unwarranted variation in the provision of treatment around the UK. The data suggest that there is limited access to immunotherapy in the devolved nations. Access is also reduced by socioeconomic deprivation. White participants were more likely to receive a direct referral from primary care than those from other ethnic groups whose referral pathways were more complex. Registry data are limited by participant enrolment and may have selection bias. Nevertheless, BRIT has highlighted inequity in access to specialist allergy services in the UK.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- University of Southampton and Southampton Children's Hospital, Southampton, UK.
- Department of Social Statistics and Demography, University of Southampton, Southampton, UK.
- British Society for Allergy and Clinical Immunology, London, UK.
- University Hospital Southampton, Southampton, UK.
- Anaphylaxis UK, Farnborough, UK.
- Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
ORCID profiles: Mich Erlewyn-Lajeunesse, Louise Michaelis
Cite
APA
Erlewyn-Lajeunesse, M., Villa, L. P., Shaikh, S., Smith, M., Balodima, V., Baker, S., Dawson, T., Ewan, P., Khan, S., Marriage, D., Michaelis, L., Ozygit, L. P., Thursby-Pelham, A., Warner, A., Maslovskaya, O., & BRIT Practitioners Group (2025). Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy ( BRIT ). Clinical & Experimental Allergy, 55(6), 458-468. https://doi.org/10.1111/cea.70034
Vancouver
Erlewyn-Lajeunesse M, Villa LP, Shaikh S, Smith M, Balodima V, Baker S, et al. Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy ( BRIT ). Clinical & Experimental Allergy. 2025;55(6):458-468. doi:10.1111/cea.70034
BibTeX
@article{ErlewynLajeunesse2025,
author = {Erlewyn-Lajeunesse, Mich and Villa, Luciano Perfetti and Shaikh, Shifa and Smith, Maria and Balodima, Vasiliki and Baker, Sarah and Dawson, Tom and Ewan, Pamela and Khan, Sujoy and Marriage, Deborah and Michaelis, Louise and Ozygit, Leyla Pur and Thursby-Pelham, Anna and Warner, Amena and Maslovskaya, Olga and BRIT Practitioners Group, BRIT Practitioners Group},
title = {Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy ( BRIT )},
journal = {Clinical & Experimental Allergy},
year = {2025},
volume = {55},
number = {6},
pages = {458--468},
doi = {10.1111/cea.70034}
}
EUVIMED